Natpara (parathyroid hormone subcutaneous injection) — Medica

Initial criteria

• Patient cannot be well-controlled on calcium supplements and active forms of vitamin D alone
• Patient’s 25-hydroxyvitamin D stores are sufficient (before initiating Natpara therapy) according to the prescriber
• Patient’s serum calcium concentration is > 7.5 mg/dL before initiating Natpara therapy
• Medication is prescribed by or in consultation with an endocrinologist or a nephrologist

Reauthorization criteria

• Patient cannot be well-controlled on calcium supplements and active forms of vitamin D alone
• Patient’s 25-hydroxyvitamin D stores are sufficient (during Natpara therapy) according to the prescriber
• Patient is responding to Natpara therapy according to the prescriber (response may include reduction in oral calcium dose, reduction in active vitamin D dose, or maintenance of a stable albumin-corrected total serum calcium concentration)

Approval duration

1 year